Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ACTION HIV (Anal Cancer TherapIes and Outcomes iNitiative for Patients Living With and Without HIV): A Global Record of Patients With Anal Squamous Cell Carcinoma With and Without HIV Infection

NCT05328765 is registered in ClinicalTrials.gov with Latin American Cooperative Oncology Group as lead sponsor.

NCT NCT05328765
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05328765 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ACTION HIV (Anal Cancer TherapIes and Outcomes iNitiative for Patients Living With and Without HIV): A Global Record of Patients With Anal Squamous Cell Carcinoma With and Without HIV Infection
Lead sponsor
Latin American Cooperative Oncology Group
Phase
Observational
Overall status
Completed
Start date
June 9, 2023
Completion date
February 7, 2025
Enrollment
369 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

anal squamous cell carcinoma, hiv infections